Authors: Runnebaum, IB Wang-Gohrke, S Vesprini, D Kreienberg, R Lynch, H Moslehi, R Ghadirian, P Weber, B Godwin, AK Risch, H Garber, J Lerman, C Olopade, OI Foulkes, WD Karlan, B Warner, E Rosen, B Rebbeck, T Tonin, P Dube, MP Kieback, DG Narod, SA

Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638

Authors: Moslehi, R Russo, D Phelan, C Jack, E Antman, K Narod, S

Citation: R. Moslehi et al., An unaffected individual from a breast/ovarian cancer family with germlinemutations in both BRCA1 and BRCA2, CLIN GENET, 57(1), 2000, pp. 70-73

Authors: Moslehi, R Chu, W Karlan, B Fishman, D Risch, H Fields, A Smotkin, D Ben-David, Y Rosenblatt, J Russo, D Schwartz, P Tung, N Warner, E Rosen, B Friedman, J Brunet, JS Narod, SA

Citation: R. Moslehi et al., BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer, AM J HU GEN, 66(4), 2000, pp. 1259-1272

Authors: Warner, E Foulkes, W Goodwin, P Meschino, W Blondal, J Paterson, C Ozcelik, H Goss, P Allingham-Hawkins, D Hamel, N Di Prospero, L Contiga, V Serruya, C Klein, M Moslehi, R Honeyford, J Liede, A Glendon, C Brunet, JS Narod, S

Citation: E. Warner et al., Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer, J NAT CANC, 91(14), 1999, pp. 1241-1247

Authors: Wang-Gohrke, S Weikel, W Risch, H Vesprini, D Abrahamson, J Lerman, C Godwin, A Moslehi, R Olipade, O Brunet, JS Stickeler, E Kieback, DG Kreienberg, R Weber, B Narod, SA Runnebaum, IB

Citation: S. Wang-gohrke et al., Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations, BR J CANC, 81(1), 1999, pp. 179-183